IBT Lower Saxony funds new biotherapeutic with 1M Euro for the proactive reduction of antimicrobial-resistant infections

At the 6th Portfolio Conference of the Institute for Biomedical Translation (IBT) Lower Saxony at Medical Park Hannover, the “DeColi” project of the Helmholtz Centre for Infection Research (HZI) in Braunschweig was awarded a grant of approximately 1 million euros. DeColi takes a preventive approach: Instead of reacting to infections that have already developed, the project aims to specifically eliminate Gram-negative pathogens from the gut reservoir before they cause disease. A total of 2.3 million euros was awarded at the conference. In addition to DeColi, the “Pathopress” project by the University Medical Center Göttingen and HAWK Göttingen received funding.

Read more in the original article from Helmholtz Centre for Infection Research

Next
Next

Arvalus project receives 2.2€ Million funding from DZIF